,

Ittehad Chemicals Limted (ICL) – HOLD Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚑ Flash Analysis for ICL

Market notice for ICL.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 139.99
P/E Ratio
9.81

πŸ“Œ Key Investment Takeaways

  • See detailed PDF

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 45.00%
YTD Change -11.62%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: July 21, 2026

Ittehad Chemicals Limted (ICL) – HOLD Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚑ Flash Analysis for ICL

Market notice for ICL.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 137.80
P/E Ratio
9.66

πŸ“Œ Key Investment Takeaways

  • See detailed PDF

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 45.00%
YTD Change -13.01%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: July 20, 2026

Ittehad Chemicals Limted (ICL) – HOLD Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a HOLD signal with a strength of 5/10.

⚑ Flash Analysis for ICL

Market notice for ICL.

Signal
HOLD ⏸️
Reaction
NEUTRAL
Current Price
Rs. 151.00
P/E Ratio
10.58

πŸ“Œ Key Investment Takeaways

  • See detailed PDF

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 45.00%
YTD Change -4.67%

🎯 Investment Thesis

Analysis unavailable.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: June 30, 2026

Ittehad Chemicals Limted (ICL) – BUY Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 8/10.

⚑ Flash Analysis for ICL

Ittehad Chemicals Limited (ICL) presented its Corporate Briefing Session for FY 2025-26, highlighting strong financial performance, strategic growth initiatives including new plants and efficiency improvements, and a positive future outlook. The company also showcased its commitment to sustainability and corporate social responsibility.

Signal
BUY πŸ“ˆ
Reaction
GAP UP
Current Price
Rs. 151.00
P/E Ratio
10.58

πŸ“Œ Key Investment Takeaways

  • ICL has shown consistent growth in sales, operating profit, and net profit over the past five years.
  • The company is expanding its production capacity with upcoming projects like a Flaker Plant, Biomass Power Plant, and Calcium Chloride Plant.
  • ICL’s credit rating has been upgraded, reflecting improved financial strength and liquidity.
  • The company is focusing on power cost reduction and GHG emission reduction to enhance competitiveness and appeal to environmentally conscious customers.
  • ICL is exploring opportunities in the export market to diversify its revenue streams.
  • Significant increase in cash and bank balances indicates strong liquidity position.
  • Investments in ICL Power (Subsidiary) and ongoing capital expenditure demonstrate commitment to growth.
  • The company maintains a strong ESG framework with certifications in Health & Safety, Quality, and Environmental Management.

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 45.00%
YTD Change -4.67%

🎯 Investment Thesis

Ittehad Chemicals Limited (ICL) presents a compelling investment opportunity driven by its robust financial performance, strategic expansion plans, and commitment to sustainability. The company’s consistent growth in revenue and profits, coupled with planned capacity expansions through new plants and efficiency improvements, indicates a strong trajectory for future earnings. The recent credit rating upgrades underscore the company’s strengthening financial health and operational efficiency. Furthermore, ICL’s focus on reducing power costs and GHG emissions positions it favorably in the market, especially for export opportunities and for attracting environmentally conscious investors. The company’s diversified product portfolio and expanding geographical sales further solidify its market position. Given these positive indicators, ICL is well-positioned for continued growth and value creation for its shareholders.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: June 29, 2026

Ittehad Chemicals Limted (ICL) – BUY Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 7/10.

⚑ Flash Analysis for ICL

Ittehad Chemicals Limited (ICL) held a Corporate Briefing Session outlining their strategy and financial highlights for FY 2025-26. The company detailed its product applications, strategic projects, credit ratings, and ESG initiatives, emphasizing growth through strategic investments and operational efficiency.

Signal
BUY πŸ“ˆ
Reaction
GAP UP
Current Price
Rs. 152.25
P/E Ratio
10.67

πŸ“Œ Key Investment Takeaways

  • ICL’s credit rating has been upgraded to ‘A’ for long-term and ‘A1’ for short-term, with a stable outlook, indicating improved financial strength and liquidity.
  • The company is undertaking significant strategic projects including a Flaker Plant, Biomass Power Plant, and Calcium Chloride Plant to enhance production capacity and reduce costs.
  • ICL is focusing on power cost reduction and GHG emission reduction to improve competitiveness in the export market and position itself as an environmentally conscious supplier.
  • Financial highlights show robust growth in revenue and operating profit for FY 2025-26, with projected increases in PAT and EPS.
  • The company has strong environmental, social, and governance (ESG) practices, with certifications in ISO 45001, ISO 9001, and ISO 14001.
  • ICL’s ‘Our Journey at Glance’ highlights consistent growth and expansion since its listing on PSX in 2003.
  • The company is exploring export market opportunities to expand its product sales globally.
  • ICL has a diverse range of products including Caustic Soda, LABSA, Liquid Chlorine, Calcium Chloride, SLES, Sodium Hypochlorite, Hydrochloric Acid, and Sodium Sulphate.

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 45.00%
YTD Change -3.88%

🎯 Investment Thesis

This corporate briefing session for Ittehad Chemicals Limited (ICL) reveals a company on a strong growth trajectory, underscored by a recent credit rating upgrade and strategic expansion plans. The company’s focus on enhancing production capacity through new plants (Flaker, Biomass Power, Calcium Chloride) and improving operational efficiency, particularly in power cost and GHG emission reduction, positions it well for increased competitiveness, especially in export markets. The positive financial outlook, with projected increases in revenue, profit, and EPS, coupled with a strong commitment to ESG principles, makes ICL an attractive investment. The recognition in Forbes Asia’s 200 Best Under a Billion list further validates its business strength and innovation. The company’s diversified product portfolio and expanding geographical sales further strengthen its market position.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: June 29, 2026

ICL Stock Analysis

Ittehad Chemicals Limted (ICL) – BUY Signal & Analysis

Ittehad Chemicals Limted (ICL) has released a new market announcement. Our AI-driven analysis suggests a BUY signal with a strength of 7/10.

⚑ Flash Analysis for ICL

Ittehad Chemicals Limited (ICL) passed resolutions at its Extraordinary General Meeting on March 27, 2026. Key among these was the approval for a long-term investment of up to PKR 1 Billion in its associated company, Biostacks (Private) Limited, over the next five years. The meeting also saw the election of new directors.

Signal
BUY πŸ“ˆ
Reaction
GAP UP
Current Price
Rs. 118.45
P/E Ratio
8.12

πŸ“Œ Key Investment Takeaways

  • ICL received shareholder approval for a substantial investment in Biostacks (Private) Limited.
  • The investment authorization is for up to PKR 1 Billion (approx. $3.4M USD based on current rates).
  • This investment is designated for ‘long-term’ purposes in the associated company.
  • The approval is valid for a period of five years, indicating a strategic, phased approach.
  • New directors were elected to the board, suggesting potential changes in governance or strategic direction.
  • The investment is in a related party, Biostacks (Private) Limited, which requires careful monitoring for related-party transaction risks.
  • This move signals ICL’s intent to expand or strengthen its ties with its associated businesses.
  • The announcement is routine but the size of the investment warrants attention.

πŸ“Š ICL Fundamental Snapshot

Live market data relative to this announcement:

EPS (Latest) N/A
EPS Growth (6.35)%
Free Float 50.00%
YTD Change -25.22%

🎯 Investment Thesis

Ittehad Chemicals Limited’s recent Extraordinary General Meeting resulted in a significant positive development for the company: shareholder approval for a long-term investment of up to PKR 1 Billion in its associated company, Biostacks (Private) Limited. This investment, authorized for a five-year period, indicates a strategic move by ICL to foster growth or synergy within its related business entities. Such capital allocation, especially into a potentially high-growth area or a key supplier/distributor, could unlock future revenue streams and operational efficiencies. The election of new directors also suggests a proactive approach to corporate governance and strategic planning. Investors should view this as a signal of ICL’s commitment to expanding its business interests and potentially enhancing shareholder value through strategic investments in its ecosystem. While the specific nature of Biostacks’ operations and the exact use of funds require further due diligence, the proactive capital deployment warrants a positive outlook.

Official Source: Download PDF Announcement

Disclaimer: This analysis is AI-generated for informational purposes and does not constitute financial advice. Data source: PSX.

Written by: FoxLogica News Analysis

Published on: March 30, 2026